4EG Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - ENGlobal Corp

Watchlist Manager

Watchlist

Price: 1.56 EUR -1.27% Market Closed

Market Cap: €12.3m

E	ENGlobal Corp F:4EG	US
B	BI Matrix Co Ltd KOSDAQ:413640	KR
	Neurobo Pharmaceuticals Inc NASDAQ:MTVA	US

Profitability Summary

ENGlobal Corp's profitability score is 29/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Gross Margin is Increasing

-16% > 7%

Negative Operating Margin

-27%

Negative 3Y Average Operating Margin

-35%

Operating Margin is Increasing

-54% > -27%

Negative Net Margin

-27%

Negative 3Y Average Net Margin

-35%

Net Margin is Increasing

-54% > -27%

Negative Free Cash Flow Margin

-6%

Negative 3Y Average Free Cash Flow Margin

-10%

Free Cash Flow Margin is Increasing

-38% > -6%

Exceptional ROE

791%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-72%

ROIC is Increasing

-122% > -65%

View All

Hide

Collapse

29 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Gross Margin is Increasing

-16% > 7%

Negative Operating Margin

-27%

Negative 3Y Average Operating Margin

-35%

Operating Margin is Increasing

-54% > -27%

Negative Net Margin

-27%